Interv. Cardiol. H. Ramón y Cajal retweeted
"Are current devices for TR repair suitable for CHD patients?" 🫀🫀🫀
Really happy to be able to participate in such a great event at the "Course: All about percutaneous pulmonary valve replacement" by the Pediatric Cardiology and CHD Department, University H. Ramón y Cajal.
Interv. Cardiol. H. Ramón y Cajal retweeted
Awesome sessions at ValveDay at the RyC Hospital. Controversies, debates and great discussions. #ValveDay @RyCImagenCardio @CardiologiaRyC @AnaGarciaMart16 @AnaPardo213 @j_alvarezgarcia
Interv. Cardiol. H. Ramón y Cajal retweeted
En el hospital Ramón y Cajal estamos de celebración #TAVI1000 @shci_sec @luisalido @CardiologiaRyC @ASanchezRecalde @ImMSanFer
Interv. Cardiol. H. Ramón y Cajal retweeted
Orgulloso de haber colaborado en "Effect of Duration of Anticoagulation in the Incidence of Stroke in Patients With Left Ventricular Thrombus" en American Journal of Cardiology @ELS_Cardiology
¡Probablemente, en trombo intraventricular tendremos beneficio en prolongar la ACO!
Interv. Cardiol. H. Ramón y Cajal retweeted
Excited to be the first center in the region #Gulf #MiddleEast to use a #TricValve more percutaneous solutions for high risk patients #Bicaval options
@KFAFHCards @fayezbaraah @drptca
productsandfeatures-kunden.d…
@sacisforum @APSIC6 @PCRonline #ACCIC #EAPCI
@Hragy @mmamas1973
Interv. Cardiol. H. Ramón y Cajal retweeted
Study shows the most widely used clinical threshold for CFRthermo (<2.0) has poor sensitivity for identifying coronary microvascular dysfunction.
Read @DrOzanDemir et al. paper to find out more: https://teapawt.net/t.co/moe65smTtO
#JACCINT #CFR #Physiology @divaka_perera #CardioTwitter
Interv. Cardiol. H. Ramón y Cajal retweeted
An expert review on the technical aspects and outcomes of the variants of the crush technique from its introduction in the early 2000s to present times.#EuroPCR #EAPCI ow.ly/cTo650JbMXE
Interv. Cardiol. H. Ramón y Cajal retweeted
33 Congreso #ACI_SEC
🗓8-10 junio☀️Alicante
Programón de #coronario y #estructural con cardiologos intervencionistas🔝 nacionales e internacionales. Comunicaciones, #LiveCases #CursoFormacion para @JovenesSec y @ResiSec y algunas sorpresas. Apuntate ya en hemodinamica.com
Interv. Cardiol. H. Ramón y Cajal retweeted
Estais ya nerviosos? Ojo a lo q viene!! Lo mejor en #Intervencionismo #Percutaneo #Cardiopatia #Estructural con los mejores expertos. Echa un ojo al programa para #medicos y #enfermeria en este 🧶 👇
Interv. Cardiol. H. Ramón y Cajal retweeted
3D anatomy Model With ECG leads.
IB for Credits.
@grepmeded
Interv. Cardiol. H. Ramón y Cajal retweeted
Thank you to my co-authors @lpbadano @denisamuraru @pe_bartko @drmaisano @PEPEZAMORANO and @DonalErwan: TR Review https://teapawt.net/t.co/l1dGh8YI7g @ESC_Journals @escardio @ASE360 @echo_stepbystep @EGarciaSayan @robertomlang
Interv. Cardiol. H. Ramón y Cajal retweeted
I think I’ll start listing that I’m 1 of 41 women in interventional cardiology at the level of Associate Professor *in the entire US* on my CV. 🤔
Interv. Cardiol. H. Ramón y Cajal retweeted
This State-of-the-Art reviews the available transcatheter therapies, main criteria for patient and device selection, remaining uncertainties, and future directions. #EAPCI ow.ly/Jfk750GSEmc
Interv. Cardiol. H. Ramón y Cajal retweeted
Desde @HemodinamicaC os deseamos #FelizNavidadParaTodos y un 2022 lleno de alegría y éxitos
#MerryChristmas
#cardioHUN #estructuralHUN – at Pamplona, Spain
Interv. Cardiol. H. Ramón y Cajal retweeted
Great course at Ramon y Cajal hospital about tricuspid valve, great presentations and the very best experts ya
Interv. Cardiol. H. Ramón y Cajal retweeted
¡Nuevo #JACCSpanish! Selección magnífica de artículos en Español
📍#TAVI en bajo riesgo a 2 años
📍#Edoxaban a mitad de dosis
📍#Empagliflozina en pts congestivos
📍Rehab 🫀 e #IC
📍#Ultraprocesados y enf CV
📍Pronóstico de pts con #IAM evolucionado
🆓 https://teapawt.net/t.co/xLhAvwVk08
Interv. Cardiol. H. Ramón y Cajal retweeted
What is your approach to coronary artery fistula closure? In this state-of-the-art review, physicians from @MayoClinicCV propose step-by-step algorithms for percutaneous closure of #CAF & highlight indications & risks https://teapawt.net/t.co/7W6K9ku8Vv
#JACCINT @AlhijjiM @aelsab @ChetRihal

ALT (A) Transarterial approach. The coronary vessel is intubated, and the fistula is wired from its origin. The delivery catheter can then be delivered to the fistula over a wire for device deployment. The occlusion device is then deployed and released. (B) Transvenous approach. The fistula termination site is intubated with the delivery catheter. The delivery catheter is advanced over a wire to the appropriate landing zone. The occlusion device is then deployed and released. (C) Arteriovenous (AV) loop approach. In large and tortuous fistulas, AV rail can be formed with the aid of a snare device to maximize support for catheter and device delivery.





































